Clinical Trial Update: Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating radiation therapy with or without epoetin alfa in anemic patients with head and neck cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Head and Neck Cancer

Snippet

Sponsor: Radiation Therapy Oncology Group | Conditions: Anemia, Head and Neck Cancer | Phase 3 | Status: COMPLETED